CTA
DRNA
Carillon Tower Advisers’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $24.7M | Sell |
1,120,359
-56,154
| -5% | -$1.24M | 0.15% | 203 |
|
|
2020
Q3 | $21.2M | Buy |
1,176,513
+56,154
| +5% | +$1.01M | 0.28% | 126 |
|
|
2020
Q2 | $28.5M | Hold |
1,120,359
| – | – | 0.22% | 146 |
|
|
2020
Q1 | $19.4M | Hold |
1,120,359
| – | – | 0.19% | 175 |
|
|
2019
Q4 | $24.7M | Hold |
1,120,359
| – | – | 0.16% | 218 |
|
|
2019
Q3 | $16.1M | Buy |
+1,120,359
| New | +$16.1M | 0.11% | 280 |
|